Showing results (171-180 of 1,241) with videos related to
Sort By:
Pageof 125
Current Medical Research and Opinion|May 30, 2008
Integrating evidence from multiple sources to evaluate post-approval safety: an example of sildenafil citrate and cardiovascular eventsRachel E Sobel, Robert F ReynoldsCardiology Clinics|October 27, 2004
Platelet function, coagulopathy, and impaired fibrinolysis in diabetesBurton E Sobel, David J SchneiderProceedings of the National Academy of Sciences of the United States of America|November 15, 1991
Augmentation of synthesis of plasminogen activator inhibitor type 1 by insulin and insulin-like growth factor type I: implications for vascular disease in hyperinsulinemic statesD J Schneider, B E SobelThe Journal of Clinical Endocrinology and Metabolism|February 1, 1990
Thyrotropin, acting at least partially via adenosine 3',5'-monophosphate, exerts both mitogenic and antimitogenic effects in cultured human thyroid cellsZ Kraiem, O Sadeh, E SobelJournal of the American Statistical Association|December 16, 2014
Causal Inference for fMRI Time Series Data with Systematic Errors of Measurement in a Balanced On/Off Study of Social Evaluative ThreatMichael E Sobel, Martin A LindquistCardiology Clinics|February 1, 1987
Factors contributing to the emergence of coronary thrombolysisA J Tiefenbrunn, B E SobelJournal of the American College of Cardiology|August 23, 2003
Synergistic treatment of ST-segment elevation myocardial infarction with pharmacoinvasive recanalizationHarold L Dauerman, Burton E SobelThe Journal of Urology|January 12, 2005
Cell lines used in prostate cancer research: a compendium of old and new lines--part 2R E Sobel, M D SadarCurrent Opinion in Pharmacology|March 23, 2005
Cardiovascular complications in diabetes mellitusBurton E Sobel, David J SchneiderBlood|May 1, 1988
Lack of interference by heparin with thrombolysis or binding of tissue-type plasminogen activator to thrombiE T Fry, B E SobelPageof 125